{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:13:57Z","timestamp":1783401237416,"version":"3.54.6"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Suzhou Science-Education Health Enhancement Project","award":["MSXM2024014"],"award-info":[{"award-number":["MSXM2024014"]}]},{"name":"Suzhou City Youth Science and Technology Project for the Promotion of Health and Education","award":["KJXW2023083"],"award-info":[{"award-number":["KJXW2023083"]}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SYW2024056"],"award-info":[{"award-number":["SYW2024056"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Suzhou Clinical Center for Rare Disease","award":["Szlcyxzxj202105"],"award-info":[{"award-number":["Szlcyxzxj202105"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-02976-5","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:45:03Z","timestamp":1778730303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cascade screening and genetic variant pathogenicity assessment for familial hypercholesterolemia in a township\u2011based elderly population"],"prefix":"10.1186","volume":"25","author":[{"given":"Hongying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"2976_CR1","doi-asserted-by":"publisher","first-page":"15282","DOI":"10.1038\/s41598-017-15543-x","volume":"7","author":"MD Di Taranto","year":"2017","unstructured":"Di Taranto MD, Benito-Vicente A, Giacobbe C, Uribe KB, Rubba P, Etxebarria A, Guardamagna O, Gentile M, Martin C, Fortunato G. Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia. Sci Rep. 2017;7:15282.","journal-title":"Sci Rep"},{"key":"2976_CR2","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","volume":"75","author":"SO Beheshti","year":"2020","unstructured":"Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects. J Am Coll Cardiol. 2020;75:2553\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"2976_CR3","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","volume":"141","author":"P Hu","year":"2020","unstructured":"Hu P, Dharmayat KI, Stevens CAT, Sharabiani MTA, Jones RS, Watts GF, Genest J, Ray KK, Vallejo-Vaz AJ. Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis. Circulation. 2020;141:1742\u201359.","journal-title":"Circulation"},{"key":"2976_CR4","doi-asserted-by":"publisher","first-page":"17093","DOI":"10.1038\/nrdp.2017.93","volume":"3","author":"JC Defesche","year":"2017","unstructured":"Defesche JC, Gidding SS, Harada-Shiba M, Hegele RA, Santos RD, Wierzbicki AS. Familial hypercholesterolaemia. Nat Rev Dis Primers. 2017;3:17093.","journal-title":"Nat Rev Dis Primers"},{"key":"2976_CR5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","volume":"44","author":"M Cuchel","year":"2023","unstructured":"Cuchel M, Raal FJ, Hegele RA, Al-Rasadi K, Arca M, Averna M, Bruckert E, Freiberger T, Gaudet D, Harada-Shiba M, et al. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. Eur Heart J. 2023;44:2277\u201391.","journal-title":"Eur Heart J"},{"key":"2976_CR6","doi-asserted-by":"publisher","first-page":"927504","DOI":"10.3389\/fgene.2022.927504","volume":"13","author":"I Diboun","year":"2022","unstructured":"Diboun I, Al-Sarraj Y, Toor SM, Mohammed S, Qureshi N, Al Hail MSH, Jayyousi A, Al Suwaidi J, Albagha OME. The Prevalence and Genetic Spectrum of Familial Hypercholesterolemia in Qatar Based on Whole Genome Sequencing of 14,000 Subjects. Front Genet. 2022;13:927504.","journal-title":"Front Genet"},{"key":"2976_CR7","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34:3478\u2013a3490.","journal-title":"Eur Heart J"},{"key":"2976_CR8","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","volume":"2","author":"J Slack","year":"1969","unstructured":"Slack J. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet. 1969;2:1380\u20132.","journal-title":"Lancet"},{"key":"2976_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/01.CIR.49.3.476","volume":"49","author":"NJ Stone","year":"1974","unstructured":"Stone NJ, Levy RI, Fredrickson DS, Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation. 1974;49:476\u201388.","journal-title":"Circulation"},{"key":"2976_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/MOL.0000000000000926","volume":"35","author":"SE van den Bosch","year":"2024","unstructured":"van den Bosch SE, Hutten BA, Corpeleijn WE, Kusters DM. Familial hypercholesterolemia in children and the importance of early treatment. Curr Opin Lipidol. 2024;35:126\u201332.","journal-title":"Curr Opin Lipidol"},{"key":"2976_CR11","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","volume":"381","author":"IK Luirink","year":"2019","unstructured":"Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, de Groot E, Kastelein JJP, Hutten BA. 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia. N Engl J Med. 2019;381:1547\u201356.","journal-title":"N Engl J Med"},{"key":"2976_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/MOL.0000000000000832","volume":"33","author":"TP Leren","year":"2022","unstructured":"Leren TP, Bogsrud MP. Cascade screening for familial hypercholesterolemia should be organized at a national level. Curr Opin Lipidol. 2022;33:231\u20136.","journal-title":"Curr Opin Lipidol"},{"key":"2976_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jacl.2020.02.006","volume":"14","author":"EE Brown","year":"2020","unstructured":"Brown EE, Byrne KH, Davis DM, McClellan R, Leucker T, Jones SR, Martin SS. Incorporation of genetic testing significantly increases the number of individuals diagnosed with familial hypercholesterolemia. J Clin Lipidol. 2020;14:331\u20138.","journal-title":"J Clin Lipidol"},{"key":"2976_CR14","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S2213-8587(25)00286-4","volume":"13","author":"RD Santos","year":"2025","unstructured":"Santos RD, Gidding SS, Bourbon M, Iatan I, Harada-Shiba M, Raal FJ, Vallejo-Vaz AJ, Wiegman A, Watts GF. Recent advances in research and care of familial hypercholesterolaemia. Lancet Diabetes Endocrinol. 2025;13:1054\u201371.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2976_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/febs.15036","volume":"287","author":"S Mikaeeli","year":"2020","unstructured":"Mikaeeli S, Susan-Resiga D, Girard E, Ben Djoudi Ouadda A, Day R, Prost S, Seidah NG. Functional analysis of natural PCSK9 mutants in modern and archaic humans. FEBS J. 2020;287:515\u201328.","journal-title":"FEBS J"},{"key":"2976_CR16","doi-asserted-by":"publisher","first-page":"bvz015","DOI":"10.1210\/jendso\/bvz015","volume":"4","author":"A Garg","year":"2020","unstructured":"Garg A, Fazio S, Duell PB, Baass A, Udata C, Joh T, Riel T, Sirota M, Dettling D, Liang H, et al. Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort. J Endocr Soc. 2020;4:bvz015.","journal-title":"J Endocr Soc"},{"key":"2976_CR17","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMoa0801936","volume":"359","author":"SC Group","year":"2008","unstructured":"Group SC, Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R. SLCO1B1 variants and statin-induced myopathy\u2013a genomewide study. N Engl J Med. 2008;359:789\u201399.","journal-title":"N Engl J Med"},{"key":"2976_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00041433-200204000-00001","volume":"13","author":"JM Ordovas","year":"2002","unstructured":"Ordovas JM, Mooser V. The APOE locus and the pharmacogenetics of lipid response. Curr Opin Lipidol. 2002;13:113\u20137.","journal-title":"Curr Opin Lipidol"},{"key":"2976_CR19","doi-asserted-by":"publisher","first-page":"a2423","DOI":"10.1136\/bmj.a2423","volume":"337","author":"J Versmissen","year":"2008","unstructured":"Versmissen J, Oosterveer DM, Yazdanpanah M, Defesche JC, Basart DC, Liem AH, Heeringa J, Witteman JC, Lansberg PJ, Kastelein JJ, Sijbrands EJ. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ. 2008;337:a2423.","journal-title":"BMJ"},{"key":"2976_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2016.04.054","volume":"68","author":"J Besseling","year":"2016","unstructured":"Besseling J, Hovingh GK, Huijgen R, Kastelein JJP, Hutten BA. Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality. J Am Coll Cardiol. 2016;68:252\u201360.","journal-title":"J Am Coll Cardiol"},{"key":"2976_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/gim.2017.151","volume":"20","author":"JR Chora","year":"2018","unstructured":"Chora JR, Medeiros AM, Alves AC, Bourbon M. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis. Genet Med. 2018;20:591\u20138.","journal-title":"Genet Med"},{"key":"2976_CR22","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jacbts.2023.03.013","volume":"8","author":"R Graca","year":"2023","unstructured":"Graca R, Zimon M, Alves AC, Pepperkok R, Bourbon M. High-Throughput Microscopy Characterization of Rare LDLR Variants. JACC Basic Transl Sci. 2023;8:1010\u201321.","journal-title":"JACC Basic Transl Sci"},{"key":"2976_CR23","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/humu.23609","volume":"39","author":"SE Brnich","year":"2018","unstructured":"Brnich SE, Rivera-Munoz EA, Berg JS. Quantifying the potential of functional evidence to reclassify variants of uncertain significance in the categorical and Bayesian interpretation frameworks. Hum Mutat. 2018;39:1531\u201341.","journal-title":"Hum Mutat"},{"key":"2976_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2021.06.001","volume":"329","author":"AC Alves","year":"2021","unstructured":"Alves AC, Azevedo S, Benito-Vicente A, Graca R, Galicia-Garcia U, Barros P, Jordan P, Martin C, Bourbon M. LDLR variants functional characterization: Contribution to variant classification. Atherosclerosis. 2021;329:14\u201321.","journal-title":"Atherosclerosis"},{"key":"2976_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jacl.2022.04.005","volume":"16","author":"R Graca","year":"2022","unstructured":"Graca R, Alves AC, Zimon M, Pepperkok R, Bourbon M. Functional profiling of LDLR variants: Important evidence for variant classification: Functional profiling of LDLR variants. J Clin Lipidol. 2022;16:516\u201324.","journal-title":"J Clin Lipidol"},{"key":"2976_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.biochem.74.082803.133354","volume":"74","author":"H Jeon","year":"2005","unstructured":"Jeon H, Blacklow SC. Structure and physiologic function of the low-density lipoprotein receptor. Annu Rev Biochem. 2005;74:535\u201362.","journal-title":"Annu Rev Biochem"},{"key":"2976_CR27","doi-asserted-by":"crossref","unstructured":"Elbitar S, Susan-Resiga D, Ghaleb Y, El Khoury P, Peloso G, Stitziel N, Rabes JP, Carreau V, Hamelin J, Ben-Djoudi-Ouadda A et al. New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia. Sci Rep. 2018;8:1943.","DOI":"10.1038\/s41598-018-20281-9"},{"key":"2976_CR28","doi-asserted-by":"publisher","first-page":"e038458","DOI":"10.1161\/JAHA.124.038458","volume":"14","author":"SS Gidding","year":"2025","unstructured":"Gidding SS, Blom DJ, McCrindle B, Ramaswami U, Santos RD, Watts GF, Wiegman A. Life Course Approach for Managing Familial Hypercholesterolemia. J Am Heart Assoc. 2025;14:e038458.","journal-title":"J Am Heart Assoc"},{"key":"2976_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11883-024-01211-9","volume":"26","author":"R Lokkesmoe","year":"2024","unstructured":"Lokkesmoe R, Hamilton L. The Role of Reverse Cascade Screening in Children with Familial Hypercholesterolemia: A Literature Review and Analysis. Curr Atheroscler Rep. 2024;26:427\u201333.","journal-title":"Curr Atheroscler Rep"},{"key":"2976_CR30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41569-023-00892-0","volume":"20","author":"GF Watts","year":"2023","unstructured":"Watts GF, Gidding SS, Hegele RA, Raal FJ, Sturm AC, Jones LK, Sarkies MN, Al-Rasadi K, Blom DJ, Daccord M, et al. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nat Rev Cardiol. 2023;20:845\u201369.","journal-title":"Nat Rev Cardiol"},{"key":"2976_CR31","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","volume":"132","author":"SS Gidding","year":"2015","unstructured":"Gidding SS, Champagne MA, de Ferranti SD, Defesche J, Ito MK, Knowles JW, McCrindle B, Raal F, Rader D, Santos RD, et al. The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. Circulation. 2015;132:2167\u201392.","journal-title":"Circulation"},{"key":"2976_CR32","doi-asserted-by":"crossref","unstructured":"Schmieder RS, Krefting J, Ates S, Schlieben LD, Arens S, Kordonouri O, Sander M, Holdenrieder S, Mall V, Meitinger T et al. Clinical scores fail to sufficiently identify children with Familial Hypercholesterolemia. Eur J Prev Cardiol. 2026;33:361\u20139.","DOI":"10.1093\/eurjpc\/zwaf301"},{"key":"2976_CR33","doi-asserted-by":"publisher","first-page":"119118","DOI":"10.1016\/j.atherosclerosis.2025.119118","volume":"402","author":"Q Ain","year":"2025","unstructured":"Ain Q, Sikonja J, Sadiq F, Shafi S, Kafol J, Gorjanc T, Sustar U, Kovac J, Khan MI, Ajmal M, Groselj U. Cascade screening of a Pakistani consanguineous familial hypercholesterolemia cohort: Identification of seven new homozygous patients. Atherosclerosis. 2025;402:119118.","journal-title":"Atherosclerosis"},{"key":"2976_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0785","volume":"86","author":"EP McCarron","year":"2025","unstructured":"McCarron EP, Rocks C, Hart P, Ryan K, Hamilton P, O\u2019Kane M. Improving Familial Hypercholesterolemia Detection Through Implementation of Nurse-led Cascade Screening. Br J Hosp Med (Lond). 2025;86:1\u201312.","journal-title":"Br J Hosp Med (Lond)"},{"key":"2976_CR35","doi-asserted-by":"crossref","unstructured":"Mourre F, Giorgi R, Cattieuw L, Gallo A, Moulin P, Charriere S, Aouchiche K, Rigalleau V, Schiele F, Sultan A et al. Cascade screening in familial hypercholesterolaemia is associated with earlier statin initiation and fewer cardiovascular events than opportunistic screening. Eur J Prev Cardiol. 2025:zwaf234.","DOI":"10.1093\/eurjpc\/zwaf234"},{"key":"2976_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/humu.1380010602","volume":"1","author":"HH Hobbs","year":"1992","unstructured":"Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992;1:445\u201366.","journal-title":"Hum Mutat"},{"key":"2976_CR37","doi-asserted-by":"publisher","first-page":"100873","DOI":"10.1016\/j.jlr.2025.100873","volume":"66","author":"K Konecna","year":"2025","unstructured":"Konecna K, Prerovska T, Loja T, Fajkusova L, Koutna J, Kramarek M, Alves AC, Bourbon M, Freiberger T, Tichy L. Functional characterization of 16 variants found in the LDL receptor gene. J Lipid Res. 2025;66:100873.","journal-title":"J Lipid Res"},{"key":"2976_CR38","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/s41598-020-58734-9","volume":"10","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Uribe KB, Jebari S, Larrea-Sebal A, Alonso-Estrada R, Aguilo-Arce J, Ostolaza H, Palacios L, Martin C. Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR. Sci Rep. 2020;10:1727.","journal-title":"Sci Rep"},{"key":"2976_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/humu.22721","volume":"36","author":"A Etxebarria","year":"2015","unstructured":"Etxebarria A, Benito-Vicente A, Palacios L, Stef M, Cenarro A, Civeira F, Ostolaza H, Martin C. Functional characterization and classification of frequent low-density lipoprotein receptor variants. Hum Mutat. 2015;36:129\u201341.","journal-title":"Hum Mutat"},{"key":"2976_CR40","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3389\/fgene.2020.01020","volume":"11","author":"Q Guo","year":"2020","unstructured":"Guo Q, Feng X, Zhou Y. PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis. Front Genet. 2020;11:1020.","journal-title":"Front Genet"},{"key":"2976_CR41","doi-asserted-by":"crossref","unstructured":"Larrea-Sebal A, Trenti C, Jebari-Benslaiman S, Bertolini S, Calandra S, Negri EA, Bonelli E, Benito-Vicente A, Uraga-Gracianteparaluceta L, Martin C, Fasano T. Functional Characterization of p.(Arg160Gln) PCSK9 Variant Accidentally Found in a Hypercholesterolemic Subject. Int J Mol Sci. 2023;24:3330.","DOI":"10.3390\/ijms24043330"},{"key":"2976_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","volume":"24","author":"JR Chora","year":"2022","unstructured":"Chora JR, Iacocca MA, Tichy L, Wand H, Kurtz CL, Zimmermann H, Leon A, Williams M, Humphries SE, Hooper AJ, et al. The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification. Genet Med. 2022;24:293\u2013306.","journal-title":"Genet Med"},{"key":"2976_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13073-019-0690-2","volume":"12","author":"SE Brnich","year":"2019","unstructured":"Brnich SE, Abou Tayoun AN, Couch FJ, Cutting GR, Greenblatt MS, Heinen CD, Kanavy DM, Luo X, McNulty SM, Starita LM, et al. Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework. Genome Med. 2019;12:3.","journal-title":"Genome Med"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02976-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02976-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02976-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:15:58Z","timestamp":1783397758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02976-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2976"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02976-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the medical ethics committee of Children\u2019s Hospital of Soochow University (Approval No. 2024CS056). All subjects voluntarily participated in the study and signed informed consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}